CBD did not prevent THC's cognitive impairment or withdrawal in mice, but showed anxiolytic effects alone | Research

The takeaway

Adding CBD to THC did not reduce THC-induced cognitive deficits or withdrawal signs in mice, but CBD alone produced anti-anxiety effects without causing dependence.

Cannabis consumers, product formulators, and researchers studying CBD-THC interactions.

CBD did not counteract THC

What the researchers found

THC caused significant motor and cognitive impairment in Barnes maze; adding CBD did not attenuate these effects. Chronic THC caused CB1-mediated withdrawal signs; adding CBD did not reduce withdrawal. CBD alone did not impair cognition, did not cause CB1-dependent withdrawal, and produced anxiolytic effects that persisted even when attempting to precipitate withdrawal.

Why it matters

The popular belief that CBD counteracts THC's negative effects was not supported in this comprehensive animal study. However, CBD's standalone safety profile (no cognitive impairment, no dependence, anxiolytic) supports its therapeutic use as a monotherapy.

The numbers in context

THC caused significant Barnes maze impairment; CBD addition did not attenuate. Chronic THC withdrawal precipitated by SR141716; CBD addition did not reduce. CBD alone: no cognitive impairment, no CB1-dependent withdrawal, significant anxiolysis.

How the study worked

Multiple dose combinations of THC, CBD, and WIN55212 tested in C57BL/6 mice. Cognition assessed via conditional discrimination and Barnes maze. Withdrawal precipitated with SR141716 (CB1 antagonist), WAY100635 (5-HT1A), capsazepine (TRPV1), and SCH58261 (A2A).

What this study cannot tell us

Mouse model; CBD-THC interactions may differ in humans. Specific dose ratios tested may not reflect real-world cannabis use. CBD's anxiolytic mechanism (not CB1-mediated) warrants further exploration.

How to read the evidence

Moderate: comprehensive dose-range animal study with multiple behavioral endpoints and receptor-specific withdrawal precipitation.

When this study was published

Published in 2019.

The bigger picture

This study challenges the widely held view that CBD can "balance out" THC in cannabis products. While CBD may modulate some THC effects at the receptor level, it did not protect against the clinically relevant outcomes of cognitive impairment and physical dependence in this model.

Questions still open

At what ratio does CBD modulate THC effects, if any? Would higher CBD:THC ratios produce different results? Does CBD's failure to prevent THC withdrawal translate to human cannabis users?

Common questions

Does CBD really counteract THC?

In this mouse study, adding CBD to THC did not reduce THC's cognitive impairment or withdrawal signs. The common belief that CBD "balances" THC was not supported.

Is CBD safe to use on its own?

CBD alone did not impair cognition, did not cause dependence or withdrawal, and produced anti-anxiety effects, supporting its safety as a standalone therapeutic agent.

Read the original research

Single and combined effects of plant-derived and synthetic cannabinoids on cognition and cannabinoid-associated withdrawal signs in mice.

British journal of pharmacology, 176(10), 1552-1567

View on PubMed ↗Publisher’s paper ↗

Citation

Myers, Alyssa M; Siegele, Patrick B; Foss, Jeffrey D; Tuma, Ronald F; Ward, Sara Jane. (2019). Single and combined effects of plant-derived and synthetic cannabinoids on cognition and cannabinoid-associated withdrawal signs in mice.. British journal of pharmacology, 176(10), 1552-1567. https://doi.org/10.1111/bph.14147